Severe Hay Fever Treatment London 2026: When Tablets Stop Working
Medically reviewed by The Online GP by The Wellness clinical team | Last updated: April 2026
Severe hay fever treatment in London should follow a structured medical pathway: optimised prescription medication first, then allergy testing to confirm triggers, then either a short oral steroid course for acute relief or allergen immunotherapy (the actual hay fever vaccine) for long-term resolution. Around 1 in 4 of the UK's 16 million hay fever sufferers, approximately 4 million people, have symptoms severe enough that standard antihistamines no longer provide adequate control. At The Online GP by The Wellness in Marylebone, every step of this pathway is delivered under one roof by GMC-registered doctors, starting from a £150 specialist consultation with same-day prescription where appropriate.
If your hay fever is keeping you awake, reducing your work performance, ruining your weekends, or worsening year on year, this guide explains exactly what is going on and what to do about it. The 2026 pollen season has started early and is forecast to be intense. The window for evidence-based intervention this year is narrowing.
Speak to a GMC-registered doctor today: WhatsApp +44 7961 280835 | Email team@thewellnesslondon.com | Call 020 3951 3429
What counts as severe hay fever?
Severe hay fever, properly termed moderate-to-severe persistent allergic rhinitis, is defined by the international ARIA (Allergic Rhinitis and its Impact on Asthma) classification system. Your symptoms qualify as severe if they meet one or more of these criteria: they disturb your sleep, impair your daily activities or sport, affect your work or school performance, or are themselves troublesome enough to demand attention. They are persistent if they occur more than 4 days per week for more than 4 consecutive weeks.
The distinction matters because severe hay fever has very different treatment needs from mild seasonal symptoms. Around 4 million people in the UK meet the severity threshold based on Allergy UK and NHS prevalence data combined with ARIA classification studies. A 2023 Imperial College London survey found that 67 percent of severe hay fever sufferers reported significant work productivity loss, 54 percent reported regular sleep disturbance, and 41 percent had reduced or stopped outdoor exercise during peak season.
The clinical hallmarks of severe hay fever beyond simple sneezing and runny nose include: persistent nasal congestion despite treatment, post-nasal drip causing throat irritation and chronic cough, sleep disturbance from nocturnal symptoms, conjunctivitis with eye redness and watering, fatigue from poor sleep and ongoing inflammation, headaches from sinus pressure, and impaired sense of smell or taste. If multiple symptoms occur together and affect daily function, your hay fever is severe regardless of how it compares to peers who tolerate the season more easily.
Why have my hay fever tablets stopped working?
If your usual hay fever tablets seem less effective than they were, the most likely explanation is not that you have built up tolerance to the medication. True pharmacological tolerance to second-generation antihistamines (cetirizine, loratadine, fexofenadine) is uncommon at licensed doses, according to BSACI and EAACI position statements. Five other explanations are far more probable.
Increased pollen exposure. UK pollen counts have risen substantially across multiple decades due to climate change, urban planting patterns, and earlier seasonal onset. The 2026 season started 4 to 6 weeks earlier than the 1990s baseline, with alder pollen peaking in late February rather than late March. Higher exposure overwhelms the same dose of medication.
Disease progression. Allergic rhinitis can worsen over time, with cumulative immune sensitisation, increased mast cell numbers, and enhanced inflammatory responses. Symptoms that were mild in your twenties can become severe in your thirties and forties without treatment ever changing.
Inadequate dosing or technique. Most patients self-managing with single OTC antihistamines never use the full evidence-based regimen. Maximum-dose fexofenadine 180mg once daily, plus consistent twice-daily intranasal corticosteroid using correct technique, plus antihistamine eye drops controls 70 to 80 percent of severe cases. The technique part matters: most people use nasal sprays incorrectly, drastically reducing effectiveness.
New triggers. Adult-onset house dust mite or pet allergy can mimic worsening hay fever. Symptoms that were only seasonal can become year-round, which patients sometimes interpret as their tablets failing rather than a new diagnosis.
Co-existing conditions. Nasal polyps, chronic rhinosinusitis, vasomotor (non-allergic) rhinitis, and local allergic rhinitis (where blood IgE tests are negative but nasal IgE is positive) can all co-exist with hay fever and respond differently to treatment. Persistent congestion not improved by antihistamines is a classic flag.
Find out why your treatment is failing: Request a same-day consultation via WhatsApp | Email team@thewellnesslondon.com
What is the best treatment for severe hay fever in 2026?
The best treatment for severe hay fever in 2026 follows a stepped care approach validated by BSACI and ARIA guidelines. The right step depends on what you have already tried, how severe your symptoms are, and your goals (one-season relief versus long-term resolution).
Step 1: Optimised prescription medication. Maximum licensed doses of three medication classes used in combination, daily, for the entire pollen season:
Antihistamine: fexofenadine 180mg once daily (preferred for severe symptoms, less sedating than cetirizine), or cetirizine 10mg, or loratadine 10mg
Intranasal corticosteroid: mometasone furoate 50mcg or fluticasone furoate 27.5mcg, two sprays per nostril once daily, with correct technique
Eye drops: olopatadine, ketotifen, or sodium cromoglycate for predominant eye symptoms
This combination regimen, when used correctly and consistently, controls 70 to 80 percent of severe cases. The Wellness GP consultation includes specific technique training for nasal spray use because misuse is the single most common reason for treatment failure.
Step 2: Add specific add-on treatments. For ongoing congestion despite step 1, add a leukotriene receptor antagonist (montelukast) which provides additional benefit particularly when there is co-existing asthma, or a decongestant nasal spray for short-term use only (maximum 5 to 7 days) to break a cycle of severe blockage.
Step 3: Short oral steroid course. For severe acute symptoms or around critical events, a 5-to-7-day course of prednisolone 30mg daily provides rapid, effective relief. This is the modern licensed equivalent of the discontinued Kenalog injection.
Step 4: Allergen immunotherapy. For sustained long-term resolution, sublingual immunotherapy (Grazax, Acarizax, or Itulazax) over three years retrains the immune system. This is the only disease-modifying treatment.
Step 5: Specialist combined approach. For complex multi-allergen cases, refractory disease, or where co-existing severe asthma complicates management, consultant allergist input may be needed alongside the GP-led pathway.
What does a severe hay fever consultation involve?
A severe hay fever consultation at The Online GP by The Wellness is a structured 30-minute appointment with a GMC-registered doctor experienced in allergic rhinitis. It produces a written diagnostic plan, immediate prescription where appropriate, and a clear pathway forward. There is no algorithmic online questionnaire substituting for clinical assessment, in line with BSACI guidance on severe rhinitis management.
Your consultation begins with a detailed allergy history. The doctor asks about symptom pattern, seasonal timing, what worsens and what helps, prior medication response, dosing technique, and the specific impact on your sleep, work, and quality of life. Validated tools may be used: the Total Nasal Symptom Score (TNSS) quantifies your current symptom burden, and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) measures functional impact.
Examination focuses on the nasal passages (looking for inflammation, polyps, septal deviation, or signs of chronic infection), throat, eyes, and chest. Where symptoms are persistent or atypical, peak flow assessment evaluates for occult asthma, which is present in around 30 to 50 percent of severe hay fever sufferers and frequently undiagnosed.
A medication review identifies whether your current treatment is at maximum licensed doses, whether technique is correct, and whether the duration of use has been long enough to assess response (intranasal steroids need 2 weeks of consistent use to reach full effect). This step alone resolves a substantial proportion of "treatment-resistant" cases.
If allergy testing is indicated to confirm triggers or guide immunotherapy planning, options include specific IgE blood testing (£295), comprehensive inhalant panels (£395), and ALEX³ molecular allergy testing (£495). Skin prick testing requires antihistamine cessation 72 hours beforehand.
By the end of your consultation, you have a working diagnosis, a written treatment plan, immediate prescription where clinically appropriate, and a follow-up plan. Most patients leave with prescription in hand on the same day.
Book a severe hay fever consultation today: WhatsApp +44 7961 280835
How effective is allergen immunotherapy for severe hay fever?
Allergen immunotherapy is the most effective long-term treatment for severe hay fever in adults, reducing symptom severity by 30 to 40 percent on average across published clinical trials and producing sustained benefit for years after the three-year course ends. Around 80 to 87 percent of patients report meaningful improvement, and 30 to 40 percent achieve near-complete remission.
Three sublingual immunotherapy products are MHRA-licensed and NICE-approved in the UK in 2026:
Grazax for grass pollen allergic rhinitis. Licensed for adults and children aged 5 and over. NICE TA246 supports use in severe disease. The largest meta-analysis (Cochrane 2010) confirmed significant reduction in symptom scores and rescue medication use.
Acarizax for house dust mite allergic rhinitis. Licensed for adults aged 18 to 65 and adolescents aged 12 to 17 with persistent moderate to severe symptoms. NICE TA1106 (January 2025) recommended NHS use. Trials in over 9,000 patients across 25 countries demonstrate consistent symptom reduction.
Itulazax for severe birch tree pollen allergic rhinoconjunctivitis. Licensed for adults aged 18 and over. NICE TA1066 (July 2025) made this the first NHS-approved tree pollen immunotherapy, potentially benefiting around 27,000 people in England with severe birch pollen allergy. Itulazax also provides cross-reactive coverage for alder and hazel pollen.
Subcutaneous immunotherapy (SCIT) is available privately for allergens not covered by the licensed sublingual tablets, including pet dander, mould, and weed pollen.
The defining feature compared with daily medication is sustained benefit. Trials of grass pollen sublingual immunotherapy have demonstrated symptom reduction maintained at least 2 to 3 years after the three-year course ends, and real-world follow-up suggests benefits often persist for 7 to 12 years. For severe sufferers facing decades of symptoms, immunotherapy is typically the most cost-effective option calculated per year of relief.
What does severe hay fever treatment cost in London?
Severe hay fever treatment costs in London depend on the level of intervention needed. Most patients can budget for an initial consultation plus 2 to 4 follow-up appointments per year for ongoing optimisation, while those choosing immunotherapy commit to a three-year course with predictable monthly costs.
The Online GP by The Wellness pricing (verified April 2026, Marylebone London W1H 6AZ):
Total cost examples:
Optimised prescription pathway: £150 to £345 (consultation, one follow-up, ongoing prescriptions). This controls 70 to 80 percent of severe cases.
Allergy testing plus optimised treatment: £445 to £695 in year 1 (consultation, IgE testing, follow-up review). Suitable for confirming triggers and planning longer-term strategy.
Full allergen immunotherapy pathway: £4,500 to £5,500 over 3 years total (consultation, testing, initiation, three years of monthly medication and reviews). Cost-effective for severe sufferers facing decades of seasonal misery.
For comparison, premium Harley Street consultant allergy clinics typically charge £250 to £500 for first consultations alone, with comprehensive testing packages £400 to £700 and immunotherapy initiation £500 to £600. The Wellness pricing sits deliberately at the premium-but-accessible level: equivalent clinical quality without the consultant-fee markup for cases that do not require consultant input.
Get a personalised quote: WhatsApp +44 7961 280835
How quickly can I get severe hay fever treatment in London?
At The Online GP by The Wellness, most patients are seen within 24 to 72 hours of first contact, with same-day phone consultations available for prescription needs. Compared with the alternatives, this is a significant difference: NHS specialist allergy clinics typically have 6 to 12 month waiting times, and even Harley Street allergy practices often have 2 to 4 week waits for new patients during peak hay fever season.
Same-day options:
Phone consultation from £59 for prescription needs and basic hay fever optimisation
In-person consultation at Marylebone from £79 for hay fever assessment and prescription
Severe Hay Fever Express Plan £195 for comprehensive same-day care including detailed assessment, prescription, and treatment plan
Next-day to within 1 week:
Hay Fever Specialist Consultation £150 with structured 30-minute appointment
Allergy blood testing with results in 24 to 48 hours
Skin prick testing in clinic with immediate 20-minute results (requires 72-hour antihistamine cessation)
Within 1 to 2 weeks:
ALEX³ molecular allergy testing results for complex cases
Immunotherapy initiation appointment following allergy test results
During pollen season (late February through August), same-day appointments are usually available but advance booking is recommended for non-urgent specialist consultations. Our medical team responds to WhatsApp enquiries within 1 to 2 hours during clinic hours and same-day for messages received before 5pm.
For urgent severe hay fever around important events (exams, weddings, weekend competitions, business presentations), we offer dedicated same-day in-person slots at Marylebone for clinically appropriate prescription including short oral steroid courses.
What allergy tests should I have for severe hay fever?
The right allergy test for severe hay fever depends on your case complexity. For most patients, a focused specific IgE blood test covering the major UK aeroallergens is sufficient and provides actionable results within 48 hours. For complex or treatment-resistant cases, more advanced testing produces additional information that changes treatment choices.
Specific IgE Hay Fever Profile (£295) covers the four allergen groups responsible for over 95 percent of UK hay fever: grass pollen (Timothy grass and others), tree pollen (birch, alder, hazel, oak, ash), weed pollen (mugwort, nettle, plantain), and house dust mite. This is the appropriate first-line test for most patients with clear seasonal symptoms.
Comprehensive Inhalant Allergy Panel (£395) adds pet allergens (cat, dog, horse), mould (Aspergillus, Cladosporium, Alternaria), and additional pollens. Suitable for patients with year-round symptoms, multi-trigger patterns, or pet exposure where contribution is uncertain.
ALEX³ Molecular Allergy Test (£495) identifies specific protein components within each allergen, distinguishing between those associated with severe systemic reactions and those associated with localised symptoms or oral allergy syndrome. This matters because two patients with positive birch pollen tests can have very different clinical pictures depending on which birch proteins their IgE recognises. ALEX³ is reserved for complex cases, multiple sensitivities, or pre-immunotherapy planning where component identification changes treatment choice.
Skin Prick Testing (£295) provides immediate 20-minute results and is preferred when rapid clinic-day diagnostic decisions are needed. The drawback is that all antihistamines must be stopped 72 hours beforehand, which is impractical for patients with severe symptoms.
Total IgE alone is rarely useful for hay fever diagnosis because elevated total IgE is not specific to allergy. Specific IgE testing for individual allergens is the appropriate approach, supported by BSACI and EAACI guidance.
A positive test indicates sensitisation, not necessarily clinical allergy. Around 15 to 20 percent of healthy people have positive specific IgE without any symptoms. Test results must always be interpreted alongside your clinical history by an experienced doctor, which is why we never offer testing without consultation.
Book your allergy testing pathway: WhatsApp our team | Email team@thewellnesslondon.com
Can severe hay fever cause asthma?
Yes. Severe untreated hay fever increases the risk of developing asthma, and the relationship goes in both directions. The "one airway, one disease" concept established by the international ARIA initiative recognises that allergic rhinitis and asthma share common inflammatory pathways: the nose and bronchial tubes are anatomically continuous and share immune cell populations, so inflammation in the upper airway tends to extend to the lower airway over time.
Prospective cohort studies have shown 3-fold higher asthma incidence in adolescents with persistent allergic rhinitis compared with peers without rhinitis. Adult studies confirm that around 30 to 40 percent of people with allergic rhinitis have co-existing asthma, and around 70 to 90 percent of people with allergic asthma have rhinitis. Treating one without addressing the other is rarely successful.
The clinical signs of co-existing asthma in severe hay fever patients include cough particularly at night or after exercise, wheeze, chest tightness, and breathlessness. Many adults with mild persistent asthma never receive the diagnosis because they attribute these symptoms to "just hay fever". Peak flow measurement during pollen season often identifies airway obstruction that resolves outside the season, suggesting allergic asthma triggered by aeroallergens.
A specialist consultation for severe hay fever should always include assessment for co-existing asthma. At The Wellness, we routinely measure peak flow, ask structured questions about lower respiratory symptoms, and examine the chest as part of severe hay fever assessment. Where asthma is suspected, spirometry can be arranged the same day or referred to colleagues for fractional exhaled nitric oxide (FeNO) testing.
The good news is that early specialist intervention reduces this risk. Allergen immunotherapy in childhood and adolescence appears to reduce the progression from allergic rhinitis to asthma, supported by multiple cohort studies and a 2018 paper in the Journal of Allergy and Clinical Immunology. For adults, treating rhinitis often improves co-existing asthma symptoms and reduces inhaler use.
Why choose The Wellness for severe hay fever treatment?
The Online GP by The Wellness is built around five principles that matter specifically for severe hay fever care: medical expertise, speed of access, comprehensive diagnostic capability, MHRA compliance, and continuity of care. Our Marylebone clinic at 10 Portman Square sits two minutes from Baker Street and immediately adjacent to Harley Street.
GMC-registered doctors with allergic rhinitis experience. Every consultation is led by a doctor with significant clinical experience managing severe hay fever, including prescription optimisation and allergen immunotherapy initiation. We do not use online questionnaires or algorithm-led prescribing for severe disease, which BSACI guidelines explicitly warn against.
Same-day and next-day appointments. While NHS specialist allergy clinics have 6 to 12 month waiting times and standard Harley Street practices have 2 to 4 week waits during pollen season, The Wellness sees most new severe hay fever patients within 24 to 72 hours.
Integrated diagnostic capability. Specific IgE blood testing, comprehensive inhalant panels, ALEX³ molecular allergy testing, and skin prick testing are all delivered from the same Marylebone location. Results are typically available within 24 to 48 hours.
MHRA-compliant care. We do not offer Kenalog or any unlicensed off-label hay fever injection. Every treatment we offer is licensed, evidence-based, and aligned with NICE and BSACI guidelines. This matters for medical record integrity, insurance compatibility, and patient safety.
Multilingual doctors including English, Arabic, Spanish, French, and Dutch speakers, supporting our substantial international patient base from the Middle East, Europe, and the United States.
Continuity of care. Whether you choose optimised prescription, short oral steroid course, or full immunotherapy pathway, you remain under the care of the same treating clinician throughout. WhatsApp access for urgent issues is available throughout your treatment.
Frequently asked questions
Should I see a GP or a consultant allergist for severe hay fever?
Most cases of severe hay fever are well-managed by an experienced GMC-registered private GP with allergy expertise. This includes prescription optimisation, short oral steroid courses, allergy testing interpretation, and sublingual immunotherapy initiation. Consultant allergist input is reserved for genuinely complex cases involving multiple-allergen sensitivities, severe co-existing asthma, atypical presentations, or treatment failure on standard regimens. The Wellness offers GP-led care with consultant referral pathways when clinically needed.
Can I have allergen immunotherapy and prescription antihistamines at the same time?
Yes. Most patients continue antihistamines and intranasal corticosteroids alongside allergen immunotherapy, particularly in the first season as immune tolerance builds. Some specialists recommend taking an antihistamine 30 to 60 minutes before each sublingual immunotherapy dose during the first month to reduce mild oral itching. Your doctor will advise on the optimal regimen.
What is the difference between Grazax, Acarizax, and Itulazax?
These three sublingual immunotherapy tablets target different allergens. Grazax treats grass pollen allergy (the most common UK hay fever trigger, peaking June to July). Acarizax treats house dust mite allergy (often year-round symptoms peaking in winter due to indoor heating). Itulazax treats silver birch tree pollen allergy and provides cross-reactive coverage for alder and hazel pollen (early spring symptoms peaking April to May). All three are MHRA-licensed and NICE-approved. The right choice depends on which allergen testing identifies as your trigger.
How do I know if my symptoms are hay fever or something else?
Around 25 to 30 percent of "hay fever" cases turn out to be non-allergic rhinitis (vasomotor rhinitis), local allergic rhinitis (where blood IgE is negative but nasal IgE is positive), chronic rhinosinusitis, or nasal polyps. Clues that suggest something other than typical hay fever include year-round symptoms, lack of response to maximum-dose antihistamines, persistent congestion without sneezing, loss of smell, or symptoms triggered by temperature changes rather than allergen exposure. A specialist consultation with appropriate testing settles the question.
Can children have severe hay fever treatment?
Yes. Children with severe hay fever benefit from the same structured approach as adults, with age-appropriate medication doses and consideration of paediatric-licensed immunotherapy options (Grazax is licensed from age 5, Acarizax from age 12). Childhood immunotherapy may also reduce the progression to asthma. Paediatric severe hay fever often requires specialist input and may be referred to paediatric allergy colleagues. Same-day GP appointments for paediatric prescription needs are available.
Will my private health insurance cover severe hay fever treatment?
Coverage varies between insurers. Most UK private medical insurance policies exclude chronic allergy management, including ongoing immunotherapy medication. However, many policies do cover specialist consultations and diagnostic testing, particularly when investigating new or worsening symptoms. Bring your insurance details to your initial consultation and our team will help you understand coverage. We provide itemised invoices for all services.
Can I have hay fever treatment while pregnant or breastfeeding?
Yes. Several hay fever treatments are considered safe in pregnancy and breastfeeding, including loratadine (preferred oral antihistamine), cetirizine (also widely used), and most intranasal corticosteroids (mometasone, fluticasone, budesonide). Sublingual immunotherapy should not be initiated during pregnancy but can be continued if already established. Oral steroid courses are usually avoided in pregnancy except for severe cases. Individual assessment is essential and our doctors are experienced in managing hay fever in pregnancy.
Book your severe hay fever consultation today
The 2026 hay fever season is exceptional. Pollen counts started 4 to 6 weeks earlier than the 1990s baseline, with alder peaking in late February. The Met Office forecasts a severe grass pollen peak in June and July following high winter soil moisture. Allergy UK estimates 16 million UK sufferers face one of the more challenging seasons in recent years, with 4 million experiencing severe symptoms.
If your hay fever has crossed the threshold from inconvenience into something that affects your sleep, your work, your weekends, or your sanity, the medical pathway to control exists. The Online GP by The Wellness offers same-day and next-day specialist consultations at our Marylebone clinic and via secure video, with the full range of licensed treatment options under one roof.
Three ways to book today:
WhatsApp: Message +44 7961 280835 for a same-day reply from our medical team.
Email: team@thewellnesslondon.com for detailed enquiries, insurance pre-authorisation, or international patient queries.
Phone: 020 3951 3429 to speak directly to our team during clinic hours.
The Wellness, 10 Portman Square, Marylebone, London W1H 6AZ. GMC-registered doctors. Same-day appointments. MHRA-compliant care. Severe hay fever, properly treated.
References and further reading
ARIA (Allergic Rhinitis and its Impact on Asthma) Guidelines, latest update 2020 with ongoing review
BSACI Guidelines for the Diagnosis and Management of Allergic and Non-Allergic Rhinitis, latest revision
NICE Technology Appraisal TA1066 (Itulazax for severe birch pollen allergic rhinitis), July 2025
NICE Technology Appraisal TA1106 (Acarizax for house dust mite allergic rhinitis), 2025
NICE Technology Appraisal TA246 (Grass pollen allergen extract), 2012
EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis
Met Office UK Pollen Calendar and Forecast, metoffice.gov.uk
Allergy UK statistics on hay fever prevalence, allergyuk.org
Imperial College London research on allergen immunotherapy outcomes, imperial.ac.uk
NHS guidance on allergic rhinitis (hay fever), nhs.uk
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Severe hay fever treatment requires individual medical assessment by a qualified healthcare provider. The Wellness is a CQC-registered private healthcare clinic with GMC-registered doctors. We operate within MHRA licensing and BSACI guidelines.
